14 Oct 2008 10:15
Phorm, Inc. ("Phorm" or the "Company")
Cancellation of admission of shares
The Company (AIM: PHRM and PHRX) announces today that 30,000 common shares of $0.001 each in the capital of the Company ("Common Shares") were cancelled from trading on the AIM market as a result of forfeiture by a former employee pursuant to Phorm's restricted stock agreement. The cancelled shares were part of the Company's PHRM/;Reg S' line of stock.
Following the cancellation of admission of these shares the Company will have a total of 13,814,863 issued and outstanding Common Shares. Of which 13,014,537 will be trading on AIM under the ticker PHRM, the 'Reg S line' and 800,326 will be trading on AIM under the ticker PHRX, the 'unrestricted line'. Phorm does not hold any shares in Treasury.
For Phorm Enquiries:
| Kent Ertugrul (Chief Executive) | +44 20 7297 2481 |
| Lynne Millar (Chief Financial Officer) | |
| Citigate Dewe Rogerson | +44 20 7638 9571 |
| Simon Rigby | |
| Justin Griffiths | |
| Canaccord Adams Limited | +44 20 7050 6500 |
| (Nominated Adviser) | |
| Mark Williams | |
| Andrew Chubb | |
PHRM.L (PHRM)